Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX0YUS
|
||||
| Drug Name |
CHEMBL1079428
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C16H13N5S
|
||||
| Canonical SMILES |
Cn1cnc(c2ccccc2)c1c3cc4c(N)ncnc4s3
|
||||
| InChI |
InChI=1S/C16H13N5S/c1-21-9-20-13(10-5-3-2-4-6-10)14(21)12-7-11-15(17)18-8-19-16(11)22-12/h2-9H,1H3,(H2,17,18,19)
|
||||
| InChIKey |
NTRDNLUCOPAXFK-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Angiopoietin 1 receptor | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathwayP00005:Angiogenesis | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.